How researchers audit an online peptide market
How researchers map and audit an unregulated online peptide market, from search surveillance to lab testing.
How researchers map and audit an unregulated online peptide market, from search surveillance to lab testing.

A 2024 investigation in the Journal of Medical Internet Research (vol 26, e65440) looked at the unregulated online sale of semaglutide. Rather than report a single result, it is useful to describe how this kind of market audit is actually done, because the method is what gives a market-quality claim any weight.
The approach combines several layers. It starts with market surveillance — mapping where these products appear online. That is followed by analysis of search results and the seller websites themselves, and by traffic analytics to understand reach. From there, researchers make controlled test purchases so that what is advertised can be compared with what is delivered. When the products arrive, the packaging is inspected against a checklist. Samples then go to the laboratory for two kinds of work: microbiological testing for sterility and endotoxin, and LC-MS quantitation to measure how much of the active molecule is actually present.
Each layer answers a different question. Surveillance and traffic analytics describe the market's size and visibility. Test purchases reveal whether buyers get what they pay for at all. Packaging inspection flags counterfeiting. Sterility and endotoxin testing address safety for anything injectable. LC-MS quantitation addresses identity and content. No single one of these is enough on its own; the value is in running them together on the same samples, with documented handling.
This is the same logic behind a complete certificate of analysis — identity, content, and safety tested together on one sample, reported together on one page.
Journal of Medical Internet Research, 2024, vol 26, e65440.
Study2017A 2017 JAMA study found only about half of products sold online as SARMs actually contained a SARM, and many held a different unapproved drug instead.
Study2024Test purchases of online 'semaglutide' found purity around 7-14% against 99% advertised, wrong amounts, and elevated endotoxin in one sample.
Regulator2024The WHO estimates at least 1 in 10 medicines in low- and middle-income countries is substandard or falsified.